Company Analysis Winner Medical Co., Ltd.
1. Summary
Advantages
- Price (24.06 Β₯) is less than fair price (35.78 Β₯)
- Dividends (4.66%) are higher than the sector average (1.83%).
- The company's current efficiency (ROE=14.55%) is higher than the sector average (ROE=11.95%)
Disadvantages
- The stock's return over the last year (-40.91%) is lower than the sector average (-36.11%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Winner Medical Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -4.3% | -4.6% | 5% |
| 90 days | -12.2% | -16% | 17.1% |
| 1 year | -40.9% | -36.1% | 42% |
300888 vs Sector: Winner Medical Co., Ltd. has slightly underperformed the "Healthcare" sector by -4.8% over the past year.
300888 vs Market: Winner Medical Co., Ltd. has significantly underperformed the market by -82.93% over the past year.
Stable price: 300888 is not significantly more volatile than the rest of the market on "Shenzhen Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 300888 with weekly volatility of -0.7868% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (24.06 Β₯) is lower than the fair price (35.78 Β₯).
Price significantly below the fair price: The current price (24.06 Β₯) is 48.7% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (14.44) is lower than that of the sector as a whole (69.4).
P/E vs Market: The company's P/E (14.44) is lower than that of the market as a whole (63.57).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2) is lower than that of the sector as a whole (3.96).
P/BV vs Market: The company's P/BV (2) is lower than that of the market as a whole (3.79).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.12) is lower than that of the sector as a whole (6.51).
P/S vs Market: The company's P/S indicator (2.12) is lower than that of the market as a whole (5.87).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (9.29) is lower than that of the sector as a whole (11.85).
EV/Ebitda vs Market: The company's EV/Ebitda (9.29) is lower than that of the market as a whole (25.54).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -11.23% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-11.23%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (14.55%) is higher than that of the sector as a whole (11.95%).
ROE vs Market: The company's ROE (14.55%) is higher than that of the market as a whole (9.38%).
5.5. ROA
ROA vs Sector: The company's ROA (7.22%) is higher than that of the sector as a whole (5.4%).
ROA vs Market: The company's ROA (7.22%) is higher than that of the market as a whole (3.95%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 4.66% is higher than the average for the sector '1.83%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 4.66% has been steadily paid over the past 7 years, DSI=0.88.
Weak dividend growth: The company's dividend yield 4.66% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (22.78%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
